Patent · US Active

Method of delivering leading blebs and agent to subretinal space

US11759355B1 · kind B1 · utility

0Cited by
4References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 21, 2020
Grant dateSep 19, 2023
Priority date
Expiry dateSep 10, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M5/158
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A method includes inserting a flexible cannula between a sclera and a choroid of an eye. The needle is advanced from a distal end of the flexible cannula, such that the needle pierces the choroid to access a subretinal space of the eye. The needle is used to deliver a first volume of leading bleb fluid to the subretinal space. The delivery of leading bleb fluid is ceased for a duration of time. After expiration of the duration of time, the needle is used to deliver a second volume of the leading bleb fluid to the subretinal space. The combination of the delivered first and second volumes of the leading bleb fluid causes a substantial portion of the retina to detach from the choroid. A therapeutic agent may then be delivered to the subretinal space in the region where the retina is detached from the choroid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.